Term
|
Definition
| A prep of killed microorganisms, living attenuated organisms, or a living, fully virulent organism that is admisistered to produce or artificially increas immunity to a particular disease. |
|
|
Term
|
Definition
| Include any of the following: generalized urticaria, angioedema, wheezing, shock, hoarseness, laryngeal edema, pruritus, cramps, nausea, stridor, chest tightness, cough, dyspnea, dizziness, tachycardia, disorientation, syncope, or sense of impending doom. |
|
|
Term
| Describe immediate interventions of Anaphylaxis |
|
Definition
E-Epinephrine
A-Airway
B-Breathing
C-Circulation
Activate Code Blue/EMS procedures |
|
|
Term
| Epinephrine Dosage for Adults |
|
Definition
| 1:1000 w/v dilution .3 mL |
|
|
Term
| Epinephrine Dosage for Children |
|
Definition
| .01 mg/kg body weight (or EpiPen Junior .15 mL, 1:2000 dilution) |
|
|
Term
| Epinephrine causes _____ and _____ . |
|
Definition
| Vasoconstriction, bronchodilation |
|
|
Term
| What gauge needle is appropriate for most Deep IM injections? |
|
Definition
|
|
Term
| What gauge needle is appropriate for most Adult IM or Pediatric Legs? |
|
Definition
|
|
Term
| What are the "Six Rights" of administering vaccines? |
|
Definition
| Right person, right time/schedule, right vaccine, right route, right dosage, and right documentation. |
|
|
Term
| Describe naturally acquired active immunity. |
|
Definition
| Exposed to a live virus, develops the disease, and become immune. |
|
|
Term
| Describe artificially acquired active immunity. |
|
Definition
| Administration of a vaccine that contains an antigen. |
|
|
Term
| Describe natually acquired passive immunity. |
|
Definition
| Occurs during pregnancy, in which certain antibodies pass through the placenta from the maternal into the fetal bloodstream. |
|
|
Term
| Describe artificailly acquired passive immunity. |
|
Definition
| Short-term immunity occurring thorugh the administration, typically by injection or IV, of antibodies that are not produced by the recipient's own immune cells. (Immune or Gamma Globulin) |
|
|
Term
| Indication of Anthrax vaccine. |
|
Definition
| Between 18-65 y/o at high risk of exposure. |
|
|
Term
| Dosage of Anthrax vaccine. |
|
Definition
| Series of five .5 mL IM doses, at -0, -4 weeks, -6 months, -12 months, and -18 months. |
|
|
Term
| Transmission of Anthrax disease. |
|
Definition
| Cutaneous, gastrointestinal, or inhalation. |
|
|
Term
| Contraindications of Anthrax vaccine. |
|
Definition
| Severe allergic reaction. |
|
|
Term
| Side Effects of Anthrax vaccine. |
|
Definition
| Fatigue, muscle ache, headache, fever, tenderness, and pain. |
|
|
Term
| Storange and managment of Anthrax vaccine. |
|
Definition
| 36-46 degrees F. Do not freeze. |
|
|
Term
| Indication of Adenovirus vaccine. |
|
Definition
| Military populations (17-50 y/o) at risk of developing ARD. |
|
|
Term
| Dosage of Adenovirus vaccine. |
|
Definition
| Orally, single dose of two tablets. One of adenovirus type 4 (white), one of adenovirus type 7 (peach). |
|
|
Term
| Transmission of Adenoviruses. |
|
Definition
| Direct contact, fecal-oral transmission, water-borne transmission. |
|
|
Term
| Contraindications of Adenovirus vaccine. |
|
Definition
| Severe allergic reaction, pregnancy, inability to swallow. |
|
|
Term
| Side effects of Adenovirus vaccine. |
|
Definition
| Headaches, URI, joint pain, abdominal pain, diarrhea, fever. |
|
|
Term
| Storage and managment of Adenovirus vaccine. |
|
Definition
| 35-46 degrees F. Do not freeze. |
|
|
